Results 81 to 90 of about 11,262 (208)

Dependency of stable Nanog states on Nanog autoregulation and noise.

open access: yes, 2014
(A) The bifurcation diagram indicates the existence of Nanog states depending on the autoregulatory transcription rate s4. The lower solid line shows the existence of Nanog-low (NL) states and the upper solid line shows the existence of Nanog-high (NH ...
Austin Smith (59569)   +4 more
core   +1 more source

CRISPR and Gene Augmentation Rescue Trabecular Meshwork Dysfunction in iPSC Models of Lowe Syndrome

open access: yesAdvanced Science, EarlyView.
By modeling Lowe syndrome using patient‐derived iPSCs, this study establishes a human disease model that faithfully recapitulates OCRL deficiency‐associated ciliary and cytoskeletal defects. The model enables evaluation of both mutation‐agnostic DNA augmentation and CRISPR‐mediated mutation correction strategies, both of which restore OCRL function and
Siyu Chen   +11 more
wiley   +1 more source

Melatonin selectively influences the transcription of pluripotency and differentiation markers in human non-cancer cells

open access: yesBiotechnology & Biotechnological Equipment, 2019
Melatonin (MEL) may influence the efficiency of reprogramming both by somatic cell nuclear transfer and by direct induction of pluripotent stem cells (iPSC) through a yet unidentified mechanism. Transcription factors linked to cell reprogramming and cell
Georgi Nikolaev Georgiev   +3 more
doaj   +1 more source

TP53 Loss Elevates NF‐κB‐IFN‐β‐MHC‐Ia Signaling to Promote NK Cell Resistance in Osteosarcoma

open access: yesAdvanced Science, EarlyView.
TP53 loss in a transforming or osteosarcoma cell promotes cytosolic DNA accumulation, activating NF‐κB‐dependent IFN‐β production. Autocrine IFN‐β signaling increases cell‐surface HLA‐Ia expression, strengthens inhibitory KIR signaling in natural killer cells, and thereby enables the affected cell to evade NK cell‐mediated cytotoxicity.
Guihui Qin   +9 more
wiley   +1 more source

Reprogramming of preiPSCs into iPSCs by Nanog+EV - GFP alone

open access: yes, 2014
Video showing the kinetics of the emergence of Nanog-GFP+ colonies from Nanog+Mbd3 transgenic preiPSCs during a 12-day culture in 2i/LIF condition.
Rodrigo Santos (562993)
core   +1 more source

A Metabolic‐Epigenetic Axis of AARS1/IGF2BP3‐K280 Lactylation Sustains Endometrial Cancer Stemness and Recurrence

open access: yesAdvanced Science, EarlyView.
Lactate‐driven endometrial cancer relapse is mediated by enzymatic protein modification. Elevated lactate levels activate AARS1, which catalyzes K280 lactylation of IGF2BP3, therefore stabilizing HMGA2 mRNA and promoting tumor stemness and recurrence.
Peng Jiang   +11 more
wiley   +1 more source

Gene Section: NANOG

open access: yes, 2016
Gene Section Review ...
Schorle, Hubert, Nettersheim, Daniel
openaire   +1 more source

Reprogramming of preiPSCs into iPSCs by Nanog+Mbd3 - GFP alone

open access: yes, 2014
Video showing the kinetics of the emergence of Nanog-GFP+ colonies from Nanog+Mbd3 transgenic preiPSCs during a 12-day culture in 2i/LIF condition.
Rodrigo Santos (562993)
core   +1 more source

Mitochondrial Localization of Cx26 Promotes Colorectal Cancer Malignancy and Exposes a Fatal Vulnerability to Drug Targeting

open access: yesAdvanced Science, EarlyView.
Mitochondrial localization of Cx26 emerges as a double‐edged sword in colorectal cancer. PIMT‐mediated methylation of Cx26 promotes its mitochondrial localization and stability. Mitochondrial Cx26 then facilitates ER‐mitochondria communication and Ca2+ signaling, thereby promoting metastatic progression. Bortezomib exploits this malignant adaptation by
Jie Wang   +9 more
wiley   +1 more source

Functional analyses of NANOG in HL-60 cells.

open access: yes, 2019
HL-60 cells were lentiviral transduced with NANOG (NANOG-1 and NANOG-2) or control vector (vector-1 and vector-2). Subsequent RQ-PCR analyses were performed for selected genes including (A) NKL homeobox genes, (B) transcription factors, (C) NOTCH-pathway
Corinna Meyer (146293)   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy